Apr 25, 2012 | BioSpace
Agenus (Formerly known as Antigenics Inc. - Lexington, MA) Reports...
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia LEXINGTON, Mass., April 25, 2012 -- Agenus Inc.
Movers & Shakers: Novato's Ultragenyx names new finance chief
Sharp has served as the chief financial officer of Agenus Inc. since 2006, and previously worked for Elan Pharmaceuticals and McKinsey & Co.
Ultragenyx Appoints as Chief Financial Officer and Senior Vice President, Finance
In this new role at Ultragenyx, Ms. Sharp will be a member of the Senior Management Team and be responsible for leading the corporate finance function.
Agenus' Brain Cancer Vaccine Phase 2 Study to be Presented at Plenary ...
Agenus Inc. reported today that Dr. Andrew Parsa, Professor in Residence, Department of Neurological Surgery, University of California San Francisco , will present an abstract entitled, " A Phase 2 multicenter trial of autologous heat shock protein-peptide vaccine for recurrent glioblastoma multiforme patients shows improved survival compared to a ... (more)
Roth Capital Begins Coverage on Agenus
Research analysts at Roth Capital initiated coverage on shares of Agenus in a report issued on Thursday.